Clinical trials
Clinical trial pathology in Australia, on one platform
Order the protocol's panel across every major Australian lab, let participants collect at any of 5,900+ centres, and export clean, structured biomarker data normalised across labs. One platform for sponsors, CROs and investigator sites.
Why trial pathology is hard in Australia
A multi-site study collects through whichever lab is near each participant, and each lab reports in its own format with its own codes and units. The data manager spends the study reconciling it. Investigators need results back fast enough to act on safety signals, and ethics approval shapes what participants may keep.
Eirly Health runs the pathology layer under the study: one order per visit, any lab, one structured dataset out.
How a study runs on Eirly Health
1. Scope the protocol
Tell us the panel, the cohort and the data you need back. We help set up the lab network and the export.
2. Order the panel
Investigators order the study panel per participant and visit, as a bundle, from the Eirly Health platform or through the API.
3. Collect anywhere
Participants collect at any of 5,900+ collection centres in every state and territory, found by location with opening hours.
4. Capture structured data
Results come back normalised across labs, each biomarker with one identity and a canonical value beside the lab's own. Webhooks tell your systems when a result arrives.
What the study gets
One lab network
Healius, Sonic Healthcare, Australian Clinical Labs, 4Cyte and specialist labs through one connection, or bring your existing lab relationships.
Clean export
Structured results with consistent units and one biomarker identity across labs, retrieved through the API.
Investigators stay in charge
Eirly Health provides the platform and the data. Clinical interpretation and return of results to participants are handled by the study's qualified investigators.
Participants may keep results
Where the protocol and ethics approval allow, participants can retain their results in their own profile after the study ends.
Hosted in Australia
The platform runs on Amazon Web Services in Australia, and an independent penetration test was completed in August 2026. Compliance.
Critical results followed up
If a lab formally notifies us of a critical result, a doctor engaged by Eirly Health follows it up.
Home visits for participants
Nurse and phlebotomist visits at the participant's home are being added through collection partners, so a study does not depend on people travelling. Bookings are not open yet.
Read about at-home collection.
Frequently asked questions
Yes. Eirly Health connects to Healius, Sonic Healthcare, Australian Clinical Labs, 4Cyte and specialist labs, so a study orders one panel per participant and visit and gets one structured dataset back, whichever lab ran the sample.
Structured results with consistent units and one biomarker identity across labs, retrieved through the API. Webhooks tell your systems when a result arrives.
The study's qualified investigators. Eirly Health provides the platform and structured data, not clinical interpretation.
Where your protocol and ethics approval allow, participants can retain their results in their own profile after the study ends.
Nurse and phlebotomist visits through collection partners are being added; bookings are not open yet. Today participants collect at any of 5,900+ centres.
Quoted to the study's volume. Book a demo.
Keep reading
- Pathology for research
Study panels across labs and clean biomarker data out.
- Pathology API
Referrals, results, webhooks, bundles and collection centres in one REST API.
- Lab results API
Results normalised across labs, with canonical values and the lab's own report text.
- Collection centres
The collection network, state by state.
Run your next study's pathology on Eirly Health.
Tell us the protocol, the cohort and the data you need back, and we will show you the platform and quote to the study's volume.